【24h】

Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain.

机译:在急性胸痛患者分流中冠状动脉MDCT的成本效益。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Patients at low risk for acute coronary syndrome (ACS) who present to the emergency department complaining of acute chest pain place a substantial economic burden on the U.S. health care system. Noninvasive 64-MDCT coronary angiography may facilitate their triage, and we evaluated its cost-effectiveness. MATERIALS AND METHODS: A microsimulation model was developed to compare costs and health effects of performing CT coronary angiography and either discharging, stress testing, or referring emergency department patients for invasive coronary angiography, depending on their severity of atherosclerosis, compared with a standard-of-care (SOC) algorithm that based management on biomarkers and stress tests alone. RESULTS: Using CT coronary angiography to triage 55-year-old men with acute chest pain increased emergency department and hospital costs by Dollars 110 and raised total health care costs by Dollars 200. In 55-year-old women, the technology was cost-saving; emergency department and hospitalcosts decreased by Dollars 410, and total health care costs decreased by Dollars 380. Compared with the SOC, CT coronary angiography-based triage extended life expectancy by 10 days in men and by 6 days in women. This translated into corresponding improvements of 0.03 quality-adjusted life years (QALYs) and 0.01 QALYs, respectively. The incremental cost-effectiveness ratio for CT coronary angiography was Dollars 6,400 per QALY in men; in women, CT coronary angiography was cost-saving. Cost-effectiveness ratios were sensitive to several parameters but generally remained in the range of what is typically considered cost-effective. CONCLUSION: CT coronary angiography-based triage for patients with low-risk chest pain is modestly more effective than the SOC. It is also cost-saving in women and associated with low cost-effectiveness ratios in men.
机译:目的:向急诊科投诉急性胸痛的低危急性冠状动脉综合征(ACS)患者为美国医疗保健系统带来了巨大的经济负担。非侵入性64-MDCT冠状动脉造影术可能有助于其分流,我们评估了其成本效益。材料与方法:开发了一种微仿真模型,用于比较CT冠状动脉造影和出院,压力测试或急诊科患者进行有创冠状动脉造影的费用和对健康的影响,具体取决于他们的动脉粥样硬化严重程度,并与标准护理(SOC)算法仅基于生物标记和压力测试进行管理。结果:使用CT冠状动脉血管造影对55岁的急性胸痛男性进行分流,增加了急诊和医院费用110美元,并增加了200美元的医疗总费用。在55岁女性中,这项技术的费用为-保存;急诊和医院的费用减少了410美元,总医疗费用减少了380美元。与SOC相比,基于CT冠状动脉造影的分流术将男性的预期寿命延长了10天,女性的预期寿命延长了6天。这分别相应地改善了0.03质量调整生命年(QALYs)和0.01 QALYs。男性CT冠状动脉造影的成本效益比增加值为6,400美元/ QALY。在女性中,CT冠状动脉造影可节省成本。成本效益比对几个参数敏感,但通常保持在通常认为具有成本效益的范围内。结论:对于低危性胸痛患者,基于CT冠状动脉造影的分流术比SOC更为有效。它还可以节省女性的成本,并降低男性的成本效益比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号